Smith F L, St John C, Yang T F, Lyness W H
Department of Pharmacology, Texas Tech University Health Sciences Center, Lubbock 79430.
Psychopharmacology (Berl). 1989;97(4):501-6. doi: 10.1007/BF00439555.
Biochemical, electrophysiological, and behavioral experiments suggest that the dopamine D-1 and D-2 receptor subtypes functionally interact. In rats trained to discriminate 1.0 mg/kg d-amphetamine, substitution with the D-2 agonist quinpirole (0.1-2.0 mg/kg) produces amphetamine-lever responding, whereas the D-1 agonist SKF 38393 (0.3-10.0 mg/kg) elicits only saline-appropriate responding. Combining either quinpirole (0.05-0.5 mg/kg) or SKF 38393 (0.5-10.0 mg/kg) with 0.3 mg/kg d-amphetamine results in dose-dependent increases in amphetamine-lever responding. Conversely, the D-1 antagonist SCH 23390 (0.02-0.1 mg/kg) antagonizes the discrimination produced by 0.7 mg/kg d-amphetamine. Additional combination studies examined the effect of DA receptor drugs on discrimination when quinpirole is substituted in d-amphetamine trained rats. SKF 38393 (0.5-7.0 mg/kg) fails to increase the amphetamine-appropriate lever response produced by either 0.05 or 0.2 mg/kg quinpirole. Similarly, SCH 23390 (0.01-0.1 mg/kg) fails to antagonize the amphetamine-lever responding produced by either 0.2 or 0.5 mg/kg quinpirole. Haloperidol (0.02-0.2 mg/kg) does antagonize the amphetamine-appropriate response produced by quinpirole substitution. The d-amphetamine discrimination studies indicate that stimulating D-2 receptors alone or D-1 receptors in the presence of d-amphetamine yields d-amphetamine-lever responding, and suggests that D-1/D-2 receptors can functionally interact to alter discrimination behavior. Quinpirole substitution, on the other hand, shows an insensitivity to D-1 receptor manipulations.
生化、电生理及行为学实验表明,多巴胺D-1和D-2受体亚型在功能上相互作用。在经训练能辨别1.0毫克/千克右旋苯丙胺的大鼠中,用D-2激动剂喹吡罗(0.1 - 2.0毫克/千克)替代会产生苯丙胺杠杆反应,而D-1激动剂SKF 38393(0.3 - 10.0毫克/千克)仅引发适用于生理盐水的反应。将喹吡罗(0.05 - 0.5毫克/千克)或SKF 38393(0.5 - 10.0毫克/千克)与0.3毫克/千克右旋苯丙胺联合使用,会导致苯丙胺杠杆反应呈剂量依赖性增加。相反,D-1拮抗剂SCH 23390(0.02 - 0.